Iovance Biotherapeutics Inc (IOVA)
SG&A Expense Growth
0.83%
Quarterly · Period ending:
IOVA SG&A Expense Growth
Latest reported0.83%period ending
Latest reported0.83%period ending
IOVA Quarterly SG&A Growth (QoQ) (0.00% → 0.83%)
Latest values, visible window
High-resolution chart · PNG
IOVA sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 0.8293% | |
| 7.0027% | |
| 5.3393% | |
| -8.0177% | |
| -14.2306% | |
| 3.0515% | |
| 7.4583% | |
| 15.6859% | |
| 30.9009% | |
| -12.6542% | |
| 10.8997% | |
| 22.9717% | |
| -22.029% | |
| 6.2691% | |
| -5.1267% | |
| 5.9442% | |
| 12.4503% | |
| -1.8282% | |
| 14.1811% | |
| 8.1836% | |
| -1.6003% | |
| 21.9984% | |
| 1.0493% | |
| 10.8897% | |
| 3.5719% | |
| 27.465% | |
| 8.4056% | |
| -7.7114% | |
| 19.6674% | |
| 20.6777% | |
| 5.7922% | |
| 4.1892% | |
| -1.9813% | |
| 29.5814% | |
| 17.1024% | |
| 16.8534% | |
| -7.7718% | |
| -16.2439% | |
| -51.5622% | |
| 44.5209% | |
| 157.7715% | |
| -28.2404% | |
| 47.6316% | |
| 11.5304% | |
| -17.7586% | |
| -8.8337% | |
| 29.8898% | |
| 40.0229% | |
| -10.6285% | |
| 99.3048% | |
| -60.0686% | |
| 215.5558% | |
| 79.1761% | |
| -70.4743% | |
| 6.894% | |
| 0.1453% | |
| -38.8444% | |
| -0.8374% | |
| -60.9735% | |
| -44.9484% | |
| 1,504.4056% | |
| 32.6911% | |
| 197.0041% | |
| 97.3638% | |
| 25.0428% | |
| 3,263.8171% | |
| -35.8623% | |
| 4.1501% | |
| -52.0306% | |
| 138.6519% | |
| -859.8223% | |
| -42.2474% | |
| -78.74% | |
| 0% |